305,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
payback
153 °P sammeln
  • Gebundenes Buch

This text additionally provides an authoritative state of the art review of the preclinical and clinical aspects of haematological malignancies and how they might impact precision oncology becoming the standard of care. It is concise, easily readable, and yet provides an authoritative review of the `state of the art¿.

Produktbeschreibung
This text additionally provides an authoritative state of the art review of the preclinical and clinical aspects of haematological malignancies and how they might impact precision oncology becoming the standard of care. It is concise, easily readable, and yet provides an authoritative review of the `state of the art¿.
Autorenporträt
Tariq I Mughal, MD, FRCP, FACP, graduated in medicine from St George's Hospital Medical School, London, and trained in hematology, medical oncology and stem cell transplantation at the University of Colorado Health Sciences Center, Denver. He is Clinical Professor of Medicine at Tufts University School of Medicine, Boston, Consultant Hematologist at Kings College NHS Foundation Trust, London, Professor of Hematology and Oncology at the University of Buckingham Medical School, UK, and the founder of Apline Oncology Foundation.